CY1105463T1 - Ελεγχομενη χορηγηση αντικαταθλιπτικων - Google Patents

Ελεγχομενη χορηγηση αντικαταθλιπτικων

Info

Publication number
CY1105463T1
CY1105463T1 CY20061100941T CY061100941T CY1105463T1 CY 1105463 T1 CY1105463 T1 CY 1105463T1 CY 20061100941 T CY20061100941 T CY 20061100941T CY 061100941 T CY061100941 T CY 061100941T CY 1105463 T1 CY1105463 T1 CY 1105463T1
Authority
CY
Cyprus
Prior art keywords
adphilistics
controlled administration
controlled
administration
triazolones
Prior art date
Application number
CY20061100941T
Other languages
English (en)
Inventor
Evangeline G. Cruz
Noymi V. Yam
Adam Zhong
Atul D. Ayer
Padmanabh Bhatt
Original Assignee
Alza Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation filed Critical Alza Corporation
Publication of CY1105463T1 publication Critical patent/CY1105463T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Περιγράφονται μορφές δόσεως και μέθοδοι για την ελεγχόμενη απελευθέρωση αντικαταθλιπτικών, όττως αυτά που δίνονται ως παράδειγμα με τις φαινοξυαιθυλ-υποκατεστημένες 1,2,4-τριαζολόνες, επί μία παρατεταμένη χρονική περίοδο.
CY20061100941T 1998-11-02 2006-07-07 Ελεγχομενη χορηγηση αντικαταθλιπτικων CY1105463T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10675898P 1998-11-02 1998-11-02
US10667798P 1998-11-02 1998-11-02
PCT/US1999/025017 WO2000025790A1 (en) 1998-11-02 1999-10-26 Controlled delivery of antidepressants

Publications (1)

Publication Number Publication Date
CY1105463T1 true CY1105463T1 (el) 2010-04-28

Family

ID=26803899

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100941T CY1105463T1 (el) 1998-11-02 2006-07-07 Ελεγχομενη χορηγηση αντικαταθλιπτικων

Country Status (13)

Country Link
EP (1) EP1126853B1 (el)
JP (1) JP4711510B2 (el)
KR (2) KR20070040421A (el)
AT (1) ATE323493T1 (el)
AU (1) AU1230800A (el)
CA (1) CA2349719C (el)
CY (1) CY1105463T1 (el)
DE (1) DE69930952T2 (el)
DK (1) DK1126853T3 (el)
ES (1) ES2260962T3 (el)
HK (1) HK1038515A1 (el)
PT (1) PT1126853E (el)
WO (1) WO2000025790A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
MXPA05001184A (es) * 2002-07-29 2005-09-12 Johnson & Johnson Formulaciones y formas de dosificacion para administracion controlada de topiramato.
WO2004010981A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Methods and dosage forms for controlled delivery of paliperidone
AU2004275835B2 (en) * 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
NZ546148A (en) 2003-09-26 2009-05-31 Alza Corp Drug coating providing high drug loading and methods for providing the same
CN101703488B (zh) * 2008-12-16 2013-02-20 北京科信必成医药科技发展有限公司 具有润滑层结构的双层渗透泵控释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
ES2124910T3 (es) * 1993-08-31 1999-02-16 Alza Corp Dispensador que contiene un agente hidrofobo.
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
DE69725345T2 (de) * 1996-02-15 2004-08-19 Janssen Pharmaceutica N.V. Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden
AU3290397A (en) * 1996-06-10 1998-01-07 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form

Also Published As

Publication number Publication date
CA2349719A1 (en) 2000-05-11
DE69930952D1 (de) 2006-05-24
WO2000025790A1 (en) 2000-05-11
EP1126853B1 (en) 2006-04-19
EP1126853A1 (en) 2001-08-29
ATE323493T1 (de) 2006-05-15
KR100734193B1 (ko) 2007-07-02
AU1230800A (en) 2000-05-22
KR20070040421A (ko) 2007-04-16
JP2002528505A (ja) 2002-09-03
HK1038515A1 (en) 2002-03-22
ES2260962T3 (es) 2006-11-01
JP4711510B2 (ja) 2011-06-29
DE69930952T2 (de) 2006-08-31
KR20010075677A (ko) 2001-08-09
DK1126853T3 (da) 2006-08-14
PT1126853E (pt) 2006-07-31
CA2349719C (en) 2009-06-02

Similar Documents

Publication Publication Date Title
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
BR0107942A (pt) Polìmeros de proteìna de liberação lenta
ES2114487B1 (es) Mezcla estabilizante sinergistica.
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
TR199900639T2 (xx) Olanzapin dihidrat D.
BR9713147A (pt) Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal.
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
CY1105463T1 (el) Ελεγχομενη χορηγηση αντικαταθλιπτικων
HUP9903931A2 (hu) Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai
DK0934065T3 (da) Hidtil ukendte cruptophycinderivater som antieoplastiske midler
AR016981A2 (es) Polipeptidos sinteticos
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
ES2181168T3 (es) Mezclas solidas a base de sulfonilureas y adyuvantes.
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
GT199900062A (es) Preparados efervescentes.
ATE233745T1 (de) Arzneistoffe
DE69206913D1 (de) Formulierungen zur Behandlung der vaginalen Trockenheit
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.